Greystone Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-925
Closed -$994K 92
2025
Q4
$994K Sell
925
-233
-20% -$223K 0.16% 65
2025
Q3
$884K Sell
1,158
-20
-2% -$14.9K 0.14% 69
2025
Q2
$918K Buy
1,178
+262
+29% +$204K 0.15% 65
2025
Q1
$757K Buy
916
+61
+7% +$50.8K 0.14% 73
2024
Q4
$660K Buy
+855
New +$708K 0.11% 77

Other funds holding LLY

Greystone Financial Group's LLY Position: Q1 2026 in Review

Greystone Financial Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 925 shares — an estimated $994K sold.

Greystone Financial Group first reported a position in LLY in Q4 2024 and held it in 5 quarters. The position peaked at $994K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Greystone Financial Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Greystone Financial Group sold 925 Eli Lilly shares in Q1 2026, an estimated $994K.
  • Greystone Financial Group first reported a position in Eli Lilly in Q4 2024 and held it in 5 quarters.
  • Greystone Financial Group's Eli Lilly position peaked at $994K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Greystone Financial Group's 13F filing for Q1 2026, filed 24 Apr 2026.